Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Finetti

Showing results (91-100 of 180) with videos related to

Pageof 18
Sort By:
Nature Communications|April 14, 2021
EFA6B regulates a stop signal for collective invasion in breast cancerRacha Fayad, Monserrat Vázquez Rojas, Mariagrazia Partisani, et al.
Journal of Translational Medicine|April 18, 2024
Mutational landscape of inflammatory breast cancerFrançois Bertucci, Florence Lerebours, Michele Ceccarelli, et al.
Plos One|February 23, 2011
High-resolution comparative genomic hybridization of inflammatory breast cancer and identification of candidate genesIsmahane Bekhouche, Pascal Finetti, José Adelaïde, et al.
Molecular Oncology|June 26, 2024
Endometrioid ovarian carcinoma landscape: pathological and molecular characterizationAlexandre de Nonneville, Elsa Kalbacher, Francesco Cannone, et al.
Haematologica|October 16, 2012
Molecular similarity between myelodysplastic form of chronic myelomonocytic leukemia and refractory anemia with ring sideroblastsVéronique Gelsi-Boyer, Nathalie Cervera, François Bertucci, et al.
Journal for Immunotherapy of Cancer|January 12, 2022
Immunologic constant of rejection signature is prognostic in soft-tissue sarcoma and refines the CINSARC signatureFrancois Bertucci, Vincent Niziers, Alexandre de Nonneville, et al.
Journal of Translational Medicine|September 19, 2023
Immunologic constant of rejection as a predictive biomarker of immune checkpoint inhibitors efficacy in non-small cell lung cancerAlice Mogenet, Pascal Finetti, Emilie Denicolai, et al.
Journal of Translational Medicine|May 1, 2015
Systems biology analysis reveals NFAT5 as a novel biomarker and master regulator of inflammatory breast cancerAndrea Remo, Ines Simeone, Massimo Pancione, et al.
Genes, Chromosomes & Cancer|March 18, 2011
Genome profiling of pancreatic adenocarcinomaDavid J Birnbaum, José Adélaïde, Emilie Mamessier, et al.
Oncotarget|October 15, 2017
Similar response profile to neoadjuvant chemotherapy, but different survival, in inflammatory <i>versus</i> locally advanced breast cancersAudrey Monneur, Anthony Goncalves, Marine Gilabert, et al.
Pageof 18

Showing results (91-100 of 180) with videos related to

Sort By:
Pageof 18
Nature Communications|April 14, 2021
EFA6B regulates a stop signal for collective invasion in breast cancerRacha Fayad, Monserrat Vázquez Rojas, Mariagrazia Partisani, et al.
Journal of Translational Medicine|April 18, 2024
Mutational landscape of inflammatory breast cancerFrançois Bertucci, Florence Lerebours, Michele Ceccarelli, et al.
Plos One|February 23, 2011
High-resolution comparative genomic hybridization of inflammatory breast cancer and identification of candidate genesIsmahane Bekhouche, Pascal Finetti, José Adelaïde, et al.
Molecular Oncology|June 26, 2024
Endometrioid ovarian carcinoma landscape: pathological and molecular characterizationAlexandre de Nonneville, Elsa Kalbacher, Francesco Cannone, et al.
Haematologica|October 16, 2012
Molecular similarity between myelodysplastic form of chronic myelomonocytic leukemia and refractory anemia with ring sideroblastsVéronique Gelsi-Boyer, Nathalie Cervera, François Bertucci, et al.
Journal for Immunotherapy of Cancer|January 12, 2022
Immunologic constant of rejection signature is prognostic in soft-tissue sarcoma and refines the CINSARC signatureFrancois Bertucci, Vincent Niziers, Alexandre de Nonneville, et al.
Journal of Translational Medicine|September 19, 2023
Immunologic constant of rejection as a predictive biomarker of immune checkpoint inhibitors efficacy in non-small cell lung cancerAlice Mogenet, Pascal Finetti, Emilie Denicolai, et al.
Journal of Translational Medicine|May 1, 2015
Systems biology analysis reveals NFAT5 as a novel biomarker and master regulator of inflammatory breast cancerAndrea Remo, Ines Simeone, Massimo Pancione, et al.
Genes, Chromosomes & Cancer|March 18, 2011
Genome profiling of pancreatic adenocarcinomaDavid J Birnbaum, José Adélaïde, Emilie Mamessier, et al.
Oncotarget|October 15, 2017
Similar response profile to neoadjuvant chemotherapy, but different survival, in inflammatory <i>versus</i> locally advanced breast cancersAudrey Monneur, Anthony Goncalves, Marine Gilabert, et al.
Pageof 18